CELLANOME BIOSYSTEMS
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jan 2026)
What this means for you
This application is over — abandoned 26 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98613988
- Mark type
- Stylized text
- Filed
- 22 Jun 2024
- Published for opposition
- 29 Apr 2025
- Abandoned
- 26 Jan 2026
- Attorney of record
- Timothy D. Sitzmann
Goods and services
- Class 001 — Chemicals: Reagents and assays for research purposes; kits comprising chemical reagents, nucleic acids featuring DNA and RNA sequences, enzymes, microfluidic chips, nucleotides featuring DNA and RNA sequences, microarray panels and flow cell cartridges in the nature of nucleic acids featuring DNA sequences for research, scientific, and industrial purposes
- Class 005 — Pharmaceuticals: Reagents for medical purposes; medical diagnostic assays for testing of biological material; kits comprising chemical reagents, nucleic acids, enzymes, microfluidic chips, nucleotides, and DNA sequences in the nature of microarray panels and flow cell cartridges in the nature of nucleic acids featuring DNA sequences, all for medical purposes
- Class 009 — Scientific and electric apparatus: Research laboratory analyzers for measuring, testing and analyzing biological samples, blood, and other bodily fluids and recorded computer software for operation and management of such research laboratory analyzers; laboratory equipment, namely, DNA and RNA microarrays and cartridges in the nature of flow cell chips for laboratory use; laboratory instrument and apparatus and computers for genetic analysis, DNA sequencing, and proteomic analysis and recorded computer software for operation and management of such laboratory equipment for performing cellular analysis; recorded computer software for molecular and cellular analysis for use in biochemical and biomedical research and for data management and analysis, data organization and storage, data sharing, and for analyzing biological samples and for operation of laboratory analyzers, for genetic analysis, and for performing cellular analysis, DNA sequencing, and RNA sequencing
- Class 042 — Scientific and technological services: Medical and scientific research; Biomedical research and biomedical research consulting services in the fields of cellular analysis, genetic analysis genomics, multiomics, biomarkers, dna sequencing, informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; providing software as a service featuring software for management and operation of laboratory equipment and laboratory analyzers; providing software as a service featuring software for research analysis and testing of cell characteristics in the field of cellular analysis, genetic analysis, genomics, multiomics, biomarkers, DNA sequencing, RNA sequencing, informatics, proteomics, secretomics, and transcriptomics; providing software as a service featuring software for analyzing biological samples and collecting, managing, sharing, and analyzing data and generating cellular images; providing software as a service featuring software for research analysis and cellular testing in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; custom design and development of chemical reagents and biochemical assays; engineering, medical and scientific research, scientific development and scientific and medical research testing services in the fields of cellular analysis, genetic analysis, genomics, multiomics, biomarkers, DNA sequencing, and informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing
- Class 044 — Medical, beauty and agricultural services: Medical testing services; medical information; medical services in the nature of medical testing, medical analysis services relating to the treatment of persons, and medical consulting services in the fields of genetic analysis, proteomic analysis, cellular analysis, multiomics, biomarkers, DNA sequencing, and informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing, all for medical purposes
Owner
- Cellanome, Inc., Foster City, CA, US
- Cellanome, Inc., Foster City, CA, US
Prosecution history
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 28 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 28 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 11 Jan 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 11 Jan 2025 — FINAL REFUSAL E-MAILED
- 11 Jan 2025 — FINAL REFUSAL WRITTEN
- 19 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED